NextCell Pharma

The total subscription value currently covered by declarations of intent amounts to approximately SEK 7.7 million, corresponding to approximately 19.9 percent of all outstanding Warrants.

As previously announced, the Company has also received binding subscription undertakings corresponding to approximately 12.0 percent of the outstanding Warrants and top guarantee commitments corresponding to approximately 30.0 percent of the total issue volume. In total, the Company has thus secured declarations of intent, subscription undertakings, and guarantee commitments amounting to approximately SEK 24.0 million, which corresponds to approximately 61.9 percent of the total issue volume.

For further information on how to exercise Warrants, please refer to the Company's press release dated May 16, 2025, and visit www.nextcellpharma.com.

Advisors
Redeye AB acts as financial advisor, and Törngren Magnell & Partners Advokatfirma KB acts as legal advisor to NextCell in connection with the exercise of the Warrants. Nordic Issuing AB acts as issuing agent.